Historical control study of paclitaxel-carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 16850129)

Published in Int J Clin Oncol on June 01, 2006

Authors

Reiko Numazaki1, Etsuko Miyagi, Ryo Onose, Tsuneo Nakazawa, Ken Sugiura, Kunio Asukai, Hiroki Nakayama, Atsushi Miyamatsu, Naoyuki Okamoto, Fumiki Hirahara

Author Affiliations

1: Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Articles cited by this

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med (1996) 11.72

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol (2003) 8.31

Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol (1989) 6.86

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst (2003) 3.77

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys (2000) 3.47

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol (1991) 2.13

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. J Clin Oncol (2000) 1.72

Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5. Gynecol Oncol (2003) 0.87

Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects. Int J Gynecol Cancer (2001) 0.86

Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93). Cancer J (2001) 0.86

First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study. Gynecol Oncol (2002) 0.83

[A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy]. Gan To Kagaku Ryoho (2000) 0.75

Clear clinical remission of a diffuse metastasized ovarian clear cell carcinoma with third line chemotherapy. Acta Obstet Gynecol Scand (1997) 0.75

Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182). Semin Oncol (2002) 0.75

Articles by these authors

New terminology for intrauterine endometrial samples: a group study by the Japanese Society of Clinical Cytology. Acta Cytol (2012) 1.99

Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One (2011) 1.73

Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol (2002) 1.59

Reproducibility and validity of a self-administered food frequency questionnaire used in the JACC study. J Epidemiol (2005) 1.57

High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin Cancer Res (2012) 1.56

N- and C-terminal Upf1 phosphorylations create binding platforms for SMG-6 and SMG-5:SMG-7 during NMD. Nucleic Acids Res (2011) 1.55

Cohort profile of the Japan Collaborative Cohort Study at final follow-up. J Epidemiol (2013) 1.33

Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res (2006) 1.30

The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort. Thyroid (2012) 1.13

HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Res (2012) 1.12

Human Papillomavirus (HPV) Vaccination Safety Assessment: The Methods Matter. Intern Med (2015) 1.09

Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma. Chest (2007) 1.07

Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy. Radiother Oncol (2003) 1.02

The Japanese guideline for cervical cancer screening. Jpn J Clin Oncol (2010) 1.00

Origin and mechanisms of formation of fetus-in-fetu: two cases with genotype and methylation analyses. Am J Med Genet A (2006) 0.99

Role of radiotherapy as curative treatment of extramammary Paget's disease. Int J Radiat Oncol Biol Phys (2010) 0.99

SMOC1 is essential for ocular and limb development in humans and mice. Am J Hum Genet (2010) 0.97

Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocr J (2006) 0.95

Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagn Pathol (2012) 0.95

Reduction of prostate motion by removal of gas in rectum during radiotherapy. Int J Radiat Oncol Biol Phys (2008) 0.94

Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab (2003) 0.94

Brief psychotic disorder associated with bereavement in a patient with terminal-stage uterine cervical cancer: a case report and review of the literature. Support Care Cancer (2003) 0.94

Inhibition of the expression of the starch synthase II gene leads to lower pasting temperature in sweetpotato starch. Plant Cell Rep (2010) 0.94

Preferential associations between oral clefts and other major congenital anomalies. Cleft Palate Craniofac J (2008) 0.94

Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res (2009) 0.93

Health management of adults with Turner syndrome: an attempt at multidisciplinary medical care by gynecologists in cooperation with specialists from other fields. J Obstet Gynaecol Res (2011) 0.92

Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics (2006) 0.91

Altered carbohydrate metabolism in the storage roots of sweet potato plants overexpressing the SRF1 gene, which encodes a Dof zinc finger transcription factor. Planta (2009) 0.91

Down-regulation of members of glycolipid-enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers. J Obstet Gynaecol Res (2004) 0.90

Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in Japan. Gynecol Oncol (2013) 0.90

Heterogeneity in binding and gene-expression regulation by HIF-2alpha. Biochem Biophys Res Commun (2008) 0.89

Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy. Int J Clin Oncol (2012) 0.89

Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women. Jpn J Clin Oncol (2006) 0.88

Retrospective study of pregnant women placed under expectant management for persistent hemorrhage. Arch Gynecol Obstet (2013) 0.88

Mass screening of newborns for congenital hypothyroidism of central origin by free thyroxine measurement of blood samples on filter paper. Eur J Endocrinol (2012) 0.88

Expression of class I knotted1-like homeobox genes in the storage roots of sweetpotato (Ipomoea batatas). J Plant Physiol (2008) 0.88

How valid are the rates of Down syndrome internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet A (2010) 0.88

Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. J Obstet Gynaecol Res (2008) 0.87

Reproductive and menstrual factors and thyroid cancer among Japanese women: the Japan Collaborative Cohort Study. J Womens Health (Larchmt) (2009) 0.87

Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis. Gynecol Oncol (2011) 0.87

Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment. Int J Cancer (2005) 0.86

Low prevalence of genetic prenatal diagnosis in Japan. Prenat Diagn (2011) 0.86

Web-based recruiting for a survey on knowledge and awareness of cervical cancer prevention among young women living in Kanagawa prefecture, Japan. Int J Gynecol Cancer (2014) 0.86

Breakpoint determination of X;autosome balanced translocations in four patients with premature ovarian failure. J Hum Genet (2010) 0.86

Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells. PLoS One (2013) 0.85

Associations of maternal pre-pregnancy underweight with small-for-gestational-age and spontaneous preterm birth, and optimal gestational weight gain in Japanese women. J Obstet Gynaecol Res (2014) 0.85

Increased incidence of extrathyroidal congenital malformations in Japanese patients with congenital hypothyroidism and their relationship with Down syndrome and other factors. Thyroid (2009) 0.85

Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker. Int J Clin Oncol (2013) 0.84

Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. J Obstet Gynaecol Res (2008) 0.84

Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia. Asian Pac J Cancer Prev (2009) 0.83

Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol (2015) 0.83

Genetic screening of 104 patients with congenitally malformed hearts revealed a fresh mutation of GATA4 in those with atrial septal defects. Cardiol Young (2009) 0.83

[A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer]. Gan To Kagaku Ryoho (2005) 0.83

The relationship between smoking habits and serum levels of 8-OHdG, oxidized LDL antibodies, Mn-SOD and carotenoids in rural Japanese residents. J Epidemiol (2003) 0.82

In vitro follicular development of cryopreserved mouse ovarian tissue. Reproduction (2005) 0.82

A locus for ophthalmo-acromelic syndrome mapped to 10p11.23. Am J Med Genet A (2009) 0.82

Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients. Int J Clin Oncol (2009) 0.82

Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis. Cancer Sci (2003) 0.81

High serum alanine aminotransferase levels for the first three successive years can predict very high incidence of hepatocellular carcinoma in patients with Child Stage A HCV-associated liver cirrhosis. Scand J Gastroenterol (2009) 0.81

Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results. J Obstet Gynaecol Res (2014) 0.81

Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: a case-control study. J Obstet Gynaecol Res (2013) 0.81

Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma. FEBS J (2011) 0.81

[A novel method for the self-collection of blood, "thenar lancing phlebotomy" and investigation of its accuracy]. Rinsho Byori (2006) 0.81

Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group. Gynecol Oncol (2004) 0.81

GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects. Endocr J (2005) 0.81

Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging (2004) 0.81

Aberrant Expression of the Cell Polarity Regulator aPKCλ/ι is Associated With Disease Progression in Cervical Intraepithelial Neoplasia (CIN): A Possible Marker for Predicting CIN Prognosis. Int J Gynecol Pathol (2016) 0.81

Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer. J Obstet Gynaecol Res (2008) 0.81

A severe vaginal hemorrhage caused by cervical endometriosis. Am J Obstet Gynecol (2008) 0.80

Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma. J Proteome Res (2013) 0.80

Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of child stage A. Intervirology (2004) 0.80

Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocr J (2015) 0.80

Gonadotropin-releasing hormone (GnRH) surge generator in female rats. Prog Brain Res (2002) 0.79

Emergency cerclage versus expectant management for prolapsed fetal membranes: a retrospective, comparative study. J Obstet Gynaecol Res (2013) 0.79

Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis. Cancer Biol Ther (2012) 0.79

Definitive radiation therapy for extramammary Paget's disease. Anticancer Res (2012) 0.79